logo image
search icon
Global Drug-coated Balloons Market

Drug-coated Balloons Market Size, Share & Trends Analysis Report By Product (Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease, and Drug-Coated Balloons for Other Indications), By End-Users, Region And Segment Forecasts, 2023-2031.

Report ID : 1099 | Published : 2023-07-07 | Pages: 180 | Format: PDF/EXCEL

The Drug-coated Balloons Market Size is valued at 594.0 Million in 2022 and is predicted to reach 1301.8 Million by the year 2031 at a 9.2 % CAGR during the forecast period for 2023-2031.

Drug-coated Balloons Market

A drug-coated balloon (DCB) is defined as a semi-compliant angioplasty balloon layered with a cytotoxic chemotherapeutic agent. At present, paclitaxel-coated balloons are gaining popularity in commercial applications. In recent years, drug-coated balloons have emerged as a stimulating technology developed to modify the limitations challenged by drug-eluting stents and are further expected to prove effective in complex subsets. Numerous drug-coated balloons identified for coronary and peripheral applications were estimated recently in preclinical and clinical studies with encouraging results.

The market is anticipated to be driven by rising technological advancements coupled with increased demand for minimally invasive surgery. The growing prevalence of Peripheral and coronary artery diseases across the globe is also considered as one of the major factors driving the market. Rapidly augmenting geriatric population with cardiovascular diseases, huge patient base in developing countries, and cumulative investments in R&D for treatment of peripheral and coronary artery diseases are the are other significant factors driving the market growth.

Market Segmentation

The global Drug-Coated Balloons Market is categorized on the basis of product, end-user, and region. On the basis of product type, the market is segmented into Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease, and Drug-Coated Balloons for Other Indications. On the basis of end-user, the market is segmented into Hospitals, Cardiac Catherization Labs, and Ambulatory Surgical Centers. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.

Competitive Landscape

Some of The Key Players in The Drug-coated Balloons Market:

  • Medtronic
  • BD
  • Koninklijke Philips
  • Braun Melsungen
  • BIOTRONIK
  • Boston Scientific
  • Opto Circuits (India)
  • Acotec Scientific
  • AR Baltic Medical
  • Acrostak
  • Biosensors International Group
  • Cardionovum
  • Concept Medical
  • ENDOCOR
  • Hexacath
  • iVascular SLU
  • A. Med Alliance
  • Minvasys
  • Orchestra BioMed
  • QT Vascular
  • RD Global-Invamed
  • Surmodics
  • Terumo
  • Wellinq
  • Other Prominent Players

The Drug-coated Balloons Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 594.0 Million

Revenue Forecast In 2031

USD 1301.8 Million

Growth Rate CAGR

CAGR of 9.2 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, By End-Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, RD Global-Invamed, Surmodics, Terumo, Welling, and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Drug-coated Balloons Market Snapshot

Chapter 4. Global Drug-coated Balloons Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2022 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Products:

5.2.1. Drug-Coated Balloons for Peripheral Artery Disease

5.2.2. Drug-Coated Balloons for Coronary Artery Disease

5.2.3. Drug-Coated Balloons for Other Indications

Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis

6.1. By End-User & Market Share, 2022& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By End-User:

6.2.1. Hospitals

6.2.2. Cardiac Catherization Labs

6.2.3. Ambulatory Surgical Centers

Chapter 7. Drug-coated Balloons Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By Products, 2022 - 2030

7.1.2. North America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

7.1.3. North America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030

7.2. Europe

7.2.1. Europe Drug-coated Balloons Market revenue (US$ Million) By Products, 2022 - 2030

7.2.2. Europe Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

7.2.3. Europe Drug-coated Balloons Market revenue (US$ Million) by country, 2022 - 2030

7.3. Asia Pacific

7.3.1. Asia Pacific Drug-coated Balloons Market revenue (US$ Million) By Products, 2022 - 2030

7.3.2. Asia Pacific Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

7.3.3. Asia Pacific Drug-coated Balloons Market revenue (US$ Million) by country, 2022 - 2030

7.4. Latin America

7.4.1. Latin America Drug-coated Balloons Market revenue (US$ Million) By Products, (US$ Million)

7.4.2. Latin America Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

7.4.3. Latin America Drug-coated Balloons Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa Drug-coated Balloons Market revenue (US$ Million) By Products, (US$ Million)

7.5.2. Middle East & Africa Drug-coated Balloons Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030

7.5.3. Middle East & Africa Drug-coated Balloons Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Medtronic

8.2.2. BD

8.2.3. Koninklijke Philips

8.2.4. Braun Melsungen

8.2.5. BIOTRONIK

8.2.6. Boston Scientific

8.2.7. Opto Circuits (India)

8.2.8. Acotec Scientific

8.2.9. AR Baltic Medical

8.2.10. Acrostak

8.2.11. Biosensors International Group

8.2.12. Cardionovum

8.2.13. Concept Medical

8.2.14. ENDOCOR

8.2.15. Hexacath

8.2.16. iVascular SLU

8.2.17. M.A. Med Alliance

8.2.18. Minvasys

8.2.19. Orchestra BioMed

8.2.20. QT Vascular

8.2.21. RD Global-Invamed

8.2.22. Surmodics

8.2.23. Terumo

8.2.24. Wellinq

8.2.25. Other prominent players

Global Drug-Coated Balloons Market Segmentation

Global Drug-Coated Balloons Market Revenue (US$ Mn) and Volume (No. of Units) Based on Product 

  • Drug-Coated Balloons for Peripheral Artery Disease
  • Drug-Coated Balloons for Coronary Artery Disease
  • Drug-Coated Balloons for Other Indications

 Drug-coated Balloons Market

Global Drug-Coated Balloons Market Revenue (US$ Mn) and Volume (No. of Units)  Based on End user

  • Hospitals
  • Cardiac Catherization Labs
  • Ambulatory Surgical Centers

 

Global Drug-Coated Balloons Market Revenue (US$ Mn) and Volume (No. of Units) Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Drug-coated Balloons Market Size?

The Drug-coated Balloons Market is expected to grow at a 9.2 % CAGR during the forecast period for 2023-2031.

Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acr

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4499
$6786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach